TipRanks
Reyon Pharmaceutical Co., Ltd. (KR:102460)
:102460
South Korea Market
102460
Reyon Pharmaceutical Co., Ltd.
RESEARCH TOOLSreports

Reyon Pharmaceutical Co., Ltd. (102460) Balance Sheet

― Followers

Reyon Pharmaceutical Co., Ltd. Balance Sheet

Reyon Pharmaceutical Co., Ltd.'s total assets for Q2 2026 were ₩444.37B, a decrease of -2.20% from the previous quarter. KR:102460 total liabilities were ₩249.50B for the fiscal quarter, a 1.92% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
₩ 465.05B₩ 499.99B₩ 499.78B₩ 484.69B₩ 477.98B
Total Liabilities
₩ 244.97B₩ 250.05B₩ 251.15B₩ 236.93B₩ 232.74B
Total Equity Gross Minority
₩ 220.08B₩ 249.94B₩ 248.62B₩ 247.77B₩ 245.24B
Other Metrics
Currency in KRW

Reyon Pharmaceutical Co., Ltd. Debt to Assets